Clinical Trials Directory

Trials / Conditions / Metastatic Merkel Cell Carcinoma

Metastatic Merkel Cell Carcinoma

8 registered clinical trials studyying Metastatic Merkel Cell Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingImmunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable
NCT05896839
National Cancer Institute (NCI)Phase 1 / Phase 2
Active Not RecruitingTesting the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and E
NCT05947500
National Cancer Institute (NCI)Phase 2
RecruitingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli
NCT05269381
Mayo ClinicPhase 1 / Phase 2
Active Not RecruitingTargeted Therapy and Avelumab in Merkel Cell Carcinoma
NCT04261855
Melanoma and Skin Cancer Trials LimitedPhase 1 / Phase 2
Active Not RecruitingTacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or M
NCT03816332
National Cancer Institute (NCI)Phase 1
CompletedA Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)
NCT03599713
Incyte CorporationPhase 2
Active Not RecruitingTesting the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma
NCT03304639
National Cancer Institute (NCI)Phase 2
Approved For MarketingExpanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)
NCT03089658
Merck KGaA, Darmstadt, Germany—